Camlin Fine Sciences Share Price

  • 103.290.10 (0.09%)
NSE
  • Live
  • As On: 30 Aug, 2024, 02:51 PM IST
  • Open103.70
  • High104.85
  • Low102.65
  • Prev Close103.20
  • Volume3,21,037
  • VWAP(₹)103.73

Camlin Fine Sc share price insights

  • PAT: Troublesome Times

    Company has posted a loss of Rs 33.95 cr for the 4th consecutive quarter. (Source: Consolidated Financials)
  • Stock Returns vs Nifty Smallcap 100

    Stock gave a 3 year return of -39.58% as compared to Nifty Smallcap 100 which gave a return of 91.39%. (as of last trading session)
  • Topline Contraction

    Sales de-grew by 3.48%. Company witnessed revenue contraction for the first time in last 3 years. (Source: Consolidated Financials)
  • Employee & Interest Expense

    Company has spent 3.74% of its operating revenues towards interest expenses and 11.08% towards employee cost in the year ending Mar 31, 2024. (Source: Consolidated Financials)
  • Camlin Fine Sc Share Price Update

    Camlin Fine Sciences Ltd. share price moved up by 0.09% from its previous close of Rs 103.20. Camlin Fine Sciences Ltd. stock last traded price is 103.29

    Share PriceValue
    Today/Current/Last103.29
    Previous Day103.20

Camlin Fine Sc Share Price Returns

1 Day0.09%
1 Month-13.11%
3 Months9.71%
1 Year-37.04%
3 Years-40.66%
5 Years86.44%

Key Metrics

PE Ratio(x)-12.24
EPS - TTM(₹)-8.49
MCap(₹ Cr.)1,741.62
MCap Rank50
PB Ratio(x)2.02
Div Yield(%)0.00
Face Value(₹)1.00
52W High(₹)186.35
52W Low(₹)79.95
MCap/Sales0.93
Beta(1 Month)2.41
BV/Share(₹)51.16

Camlin Fine Sc Share Recommendations

Mean recosCurrent
BUY

2 Analysts

Strong
Sell
SellHoldBuyStrong
Buy
Analyst Trends
RatingsCurrent1W Ago1M Ago3M Ago
Strong Buy--11
Buy11--
Hold1111
Sell----
Strong Sell----
# Analysts2222
ADVERTISEMENT
ADVERTISEMENT

Camlin Fine Sc Financials

  • Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
    Total Income397.72407.46387.55407.64425.97
    Total Income Growth (%)-2.395.14-4.93-4.30-0.64
    Total Expenses397.83484.80383.14399.95399.67
    Total Expenses Growth (%)-17.9426.53-4.200.07-2.64
    EBIT-0.11-77.344.417.6926.30
    EBIT Growth (%)--1,854.09-42.69-70.7544.43
    Profit after Tax (PAT)-33.95-77.14-11.79-19.3815.55
    PAT Growth (%)----224.6169.80
    EBIT Margin (%)-0.03-18.981.141.896.17
    Net Profit Margin (%)-8.54-18.93-3.04-4.753.65
    Basic EPS (₹)-2.03-4.64-0.71-1.170.96
    Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
    Total Income183.69225.88187.73211.85167.12
    Total Income Growth (%)-18.6820.32-11.3826.76-23.83
    Total Expenses187.67260.69192.12197.27147.82
    Total Expenses Growth (%)-28.0135.69-2.6133.46-24.03
    EBIT-3.98-34.81-4.3914.5819.31
    EBIT Growth (%)---130.10-24.50-22.19
    Profit after Tax (PAT)-13.68-44.07-11.64-1.465.78
    PAT Growth (%)----125.18-25.92
    EBIT Margin (%)-2.17-15.41-2.346.8811.55
    Net Profit Margin (%)-7.45-19.51-6.20-0.693.46
    Basic EPS (₹)-0.82-2.65-0.70-0.090.36
    FY 2024FY 2023FY 2022FY 2021FY 2020
    Total Revenue1,628.621,687.361,445.121,192.091,052.58
    Total Revenue Growth (%)-3.4816.7621.2313.2516.18
    Total Expenses1,678.061,597.311,351.011,086.99994.38
    Total Expenses Growth (%)5.0618.2324.299.3111.83
    Profit after Tax (PAT)-92.7552.1160.6850.9630.32
    PAT Growth (%)-278.01-14.1319.0668.095,152.70
    Operating Profit Margin (%)0.678.839.1912.019.65
    Net Profit Margin (%)-5.753.094.294.292.88
    Basic EPS (₹)-5.583.454.654.132.50
    FY 2024FY 2023FY 2022FY 2021FY 2020
    Total Revenue792.14818.27704.21605.52603.84
    Total Revenue Growth (%)-3.1916.2016.300.287.49
    Total Expenses849.85751.64668.14590.00559.42
    Total Expenses Growth (%)13.0712.5013.245.472.16
    Profit after Tax (PAT)-51.3947.5525.878.2830.72
    PAT Growth (%)-208.0683.82212.39-73.04186.36
    Operating Profit Margin (%)-0.4315.6510.138.0012.50
    Net Profit Margin (%)-6.646.023.771.385.29
    Basic EPS (₹)-3.093.181.980.672.53

    All figures in Rs Cr, unless mentioned otherwise

    Insights
    • PAT: Troublesome Times

      Company has posted a loss of Rs 33.95 cr for the 4th consecutive quarter. (Source: Consolidated Financials)
    • Topline Contraction

      Sales de-grew by 3.48%. Company witnessed revenue contraction for the first time in last 3 years. (Source: Consolidated Financials)
  • AnnualFY 2024FY 2023FY 2022FY 2021FY 2020
    Total Assets1,951.722,060.101,800.081,481.601,234.06
    Total Assets Growth (%)-5.2614.4421.5020.0613.55
    Total Liabilities1,094.771,236.011,035.03768.45773.96
    Total Liabilities Growth (%)-11.4319.4234.69-0.7117.89
    Total Equity853.64820.77761.74709.84456.80
    Total Equity Growth (%)4.007.757.3155.406.99
    Current Ratio (x)1.371.371.501.661.23
    Total Debt to Equity (x)0.811.040.941.001.22
    Contingent Liabilities51.6244.9953.61125.6310.55
    AnnualFY 2024FY 2023FY 2022FY 2021FY 2020
    Total Assets1,571.991,593.811,345.941,066.71891.35
    Total Assets Growth (%)-1.3718.4226.1819.6714.16
    Total Liabilities856.28951.67753.59602.08514.55
    Total Liabilities Growth (%)-10.0226.2825.1617.0118.74
    Total Equity712.40638.83589.03461.33373.49
    Total Equity Growth (%)11.528.4527.6823.528.53
    Current Ratio (x)1.421.391.531.551.31
    Total Debt to Equity (x)0.690.950.760.810.89
    Contingent Liabilities144.83135.07138.98125.63257.70

    All figures in Rs Cr, unless mentioned otherwise

  • AnnualFY 2024FY 2023FY 2022FY 2021FY 2020
    Net Cash flow from Operating Activities138.9850.90145.45117.3886.02
    Net Cash used in Investing Activities-66.50-124.63-249.13-132.86-90.12
    Net Cash flow from Financing Activities-85.9759.66135.9738.633.25
    Net Cash Flow-13.49-14.0732.2923.15-0.85
    Closing Cash & Cash Equivalent80.2593.74107.8175.5252.37
    Closing Cash & Cash Equivalent Growth (%)-14.39-13.0542.7644.21-1.59
    Total Debt/ CFO (x)4.7315.324.284.585.69
    AnnualFY 2024FY 2023FY 2022FY 2021FY 2020
    Net Cash flow from Operating Activities82.1018.5246.8026.0273.90
    Net Cash used in Investing Activities-51.72-114.73-172.33-88.00-66.03
    Net Cash flow from Financing Activities-34.0578.39128.9280.05-26.06
    Net Cash Flow-3.67-17.823.3918.08-18.19
    Closing Cash & Cash Equivalent0.684.3522.1718.780.70
    Closing Cash & Cash Equivalent Growth (%)-84.44-80.3718.062,588.73-96.30
    Total Debt/ CFO (x)5.9932.629.5714.334.48

    All figures in Rs Cr, unless mentioned otherwise

    Insights
    • Decrease in Cash from Investing

      Company has used Rs 66.5 cr for investing activities which is an YoY decrease of 46.64%. (Source: Consolidated Financials)
  • AnnualFY 2024FY 2023FY 2022FY 2021FY 2020
    Return on Equity (%)-11.356.929.169.437.58
    Return on Capital Employed (%)0.8911.7210.7714.2014.76
    Return on Assets (%)-4.752.523.373.432.45
    Interest Coverage Ratio (x)1.483.615.204.982.35
    Asset Turnover Ratio (x)0.800.470.480.5285.01
    Price to Earnings (x)-16.1338.4636.1035.0915.77
    Price to Book (x)1.832.663.313.301.19
    EV/EBITDA (x)22.9212.7214.4612.057.15
    EBITDA Margin (%)5.5412.5513.1615.7412.78
    AnnualFY 2024FY 2023FY 2022FY 2021FY 2020
    Return on Equity (%)-7.217.444.391.798.22
    Return on Capital Employed (%)-0.3512.817.937.4914.47
    Return on Assets (%)-3.262.981.920.773.44
    Interest Coverage Ratio (x)0.852.752.882.072.58
    Asset Turnover Ratio (x)0.490.540.570.6165.04
    Price to Earnings (x)-29.1542.1984.75217.3915.55
    Price to Book (x)2.103.133.723.861.28
    EV/EBITDA (x)42.8616.5926.8330.809.50
    EBITDA Margin (%)5.9519.8114.0311.2214.44
ADVERTISEMENT

Peer Comparison

Insights
  • Stock Returns vs Nifty Smallcap 100

    Stock gave a 3 year return of -39.58% as compared to Nifty Smallcap 100 which gave a return of 91.39%. (as of last trading session)

Mutual Funds Ownership

MF Ownership as on 31 July 2024

ADVERTISEMENT

Corporate Actions

  • Board Meeting

    Quarterly Results

    Aug 05, 2024

    Board Meeting

    Audited Results

    May 08, 2024

    Board Meeting

    Quarterly Results

    Jan 29, 2024

  • Announced onMeeting on
    Aug 05, 2024Aug 12, 2024
    Quarterly Results
    May 08, 2024May 20, 2024
    Audited Results
    Jan 29, 2024Feb 09, 2024
    Quarterly Results
    Oct 25, 2023Nov 06, 2023
    Quarterly Results
    Aug 01, 2023Aug 11, 2023
    Quarterly Results
  • Announced onEx-DateDividend%
    May 23, 2016Jul 28, 201645%
    May 12, 2015Jul 27, 201545%
    May 29, 2014Jul 24, 201435%
    May 21, 2013Aug 01, 201330%
    May 24, 2012Jul 23, 201225%
  • No Data Available

  • Announced onEx-Date
    Jun 17, 2014Sep 04, 2014
    Split: Old FV2.0| New FV:1.0
    Nov 10, 2011Feb 15, 2012
    Split: Old FV10.0| New FV:2.0
  • Announced onEx-Date
    Dec 01, 2009Jul 30, 2010
    Rights ratio: 3 share for every 5 held at a price of Rs 15.75
  • Announced onMeeting on
    May 23, 2023Jul 31, 2023
    A.G.M.
    May 19, 2022Jul 29, 2022
    Book closure from Jul 23, 2022 to Jul 29, 2022
    Feb 24, 2022Mar 28, 2022
    -
    May 28, 2021Aug 13, 2021
    Book closure from Aug 7, 2021 to Aug 13, 2021
    May 28, 2021-
    (Revised)
ADVERTISEMENT

About

Camlin Fine Sciences Ltd., incorporated in the year 1993, is a Small Cap company (having a market cap of Rs 1,728.55 Crore) operating in Chemicals sector.

Camlin Fine Sciences Ltd. key Products/Revenue Segments include Speciality Chemicals, Service Income, Scrap for the year ending 31-Mar-2024.

For the quarter ended 30-06-2024, the company has reported a Consolidated Total Income of Rs 397.72 Crore, down 2.39 % from last quarter Total Income of Rs 407.46 Crore and down 6.63 % from last year same quarter Total Income of Rs 425.97 Crore. Company has reported net profit after tax of Rs -34.65 Crore in latest quarter.

The company’s top management includes Mr.Ashish Dandekar, Mr.Nirmal Momaya, Mr.Arjun Dukane, Ms.Anagha Dandekar, Mr.Harsha Raghavan, Mr.Amol Shah, Mr.Joseph Conrad D'souza, Mr.Mahabaleshwar Palekar, Mr.Pradip Kanakia, Mr.Sutapa Banerjee, Mr.Santosh Parab, Mr.Rahul Sawale. Company has Kalyaniwalla & Mistry LLP as its auditors. As on 30-06-2024, the company has a total of 16.75 Crore shares outstanding.

About Camlin Fine Sc

Camlin Fine Sciences Ltd., incorporated in the year 1993, is a Small Cap company (having a market cap of Rs 1,728.55 Crore) operating in Chemicals sector. Camlin Fine Sciences Ltd. key Products/Revenue Segments include Speciality Chemicals, Service Income, Scrap for the year ending 31-Mar-2024.For the quarter ended 30-06-2024, the company has reported a Consolidated Total Income of Rs 397.72 Crore, down 2.39 % from last quarter Total Income of Rs 407.46 Crore and down 6.63 % from last year same quarter Total Income of Rs 425.97 Crore. Company has reported net profit after tax of Rs -34.65 Crore in latest quarter.The company’s top management includes Mr.Ashish Dandekar, Mr.Nirmal Momaya, Mr.Arjun Dukane, Ms.Anagha Dandekar, Mr.Harsha Raghavan, Mr.Amol Shah, Mr.Joseph Conrad D'souza, Mr.Mahabaleshwar Palekar, Mr.Pradip Kanakia, Mr.Sutapa Banerjee, Mr.Santosh Parab, Mr.Rahul Sawale. Company has Kalyaniwalla & Mistry LLP as its auditors. As on 30-06-2024, the company has a total of 16.75 Crore shares outstanding.

Key Indices Listed On

BSE SmallCap, BSE Commodities, BSE AllCap, Nifty Microcap 250, Nifty Total Market

Address

Floor 2 to 5, In GS Point,CST Road, Kalina,Santacruz East,Mumbai, Maharashtra - 400098

Executive Leadership

AD

Ashish Dandekar

Chairman & Managing Director
NM

Nirmal Momaya

Managing Director
AD

Arjun Dukane

Executive Director -Technical
AD

Anagha Dandekar

Non Exe.Non Ind.Director
Show More

Auditors

Kalyaniwalla & Mistry LLP

DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this site, you agree to the Terms of Service and Privacy Policy.

ADVERTISEMENT